Emerging Change To Operating Activities from 2010 to 2026

EWPI Stock  USD 0.0001  0.00  0.00%   
Emerging World's Change To Operating Activities is increasing with stable movements from year to year. Change To Operating Activities is predicted to flatten to about 33.9 K. For the period between 2010 and 2026, Emerging World, Change To Operating Activities quarterly trend regression had mean deviation of  3,111 and range of 25.1 K. View All Fundamentals
 
Change To Operating Activities  
First Reported
2010-12-31
Previous Quarter
51.3 K
Current Value
33.9 K
Quarterly Volatility
5.4 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Emerging World financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Emerging World's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 80.1 K or Total Revenue of 0.0, as well as many indicators such as . Emerging financial statements analysis is a perfect complement when working with Emerging World Valuation or Volatility modules.
  
Build AI portfolio with Emerging Stock
Check out the analysis of Emerging World Correlation against competitors.
The Change To Operating Activities trend for Emerging World Pharma offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Emerging World is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Emerging World's Change To Operating Activities Growth Pattern

Below is the plot of the Change To Operating Activities of Emerging World Pharma over the last few years. It is Emerging World's Change To Operating Activities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Emerging World's overall financial position and show how it may be relating to other accounts over time.
Change To Operating Activities10 Years Trend
Pretty Stable
   Change To Operating Activities   
       Timeline  

Emerging Change To Operating Activities Regression Statistics

Arithmetic Mean43,258
Geometric Mean42,862
Coefficient Of Variation12.49
Mean Deviation3,111
Median44,575
Standard Deviation5,405
Sample Variance29.2M
Range25.1K
R-Value0.25
Mean Square Error29.2M
R-Squared0.06
Significance0.34
Slope265.17
Total Sum of Squares467.4M

Emerging Change To Operating Activities History

202633.9 K
202551.3 K
201144.6 K
201026.2 K

About Emerging World Financial Statements

Investors use fundamental indicators, such as Emerging World's Change To Operating Activities, to determine how well the company is positioned to perform in the future. Although Emerging World's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Change To Operating Activities51.3 K33.9 K

Currently Active Assets on Macroaxis

When determining whether Emerging World Pharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Emerging World's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Emerging World Pharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Emerging World Pharma Stock:
Check out the analysis of Emerging World Correlation against competitors.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is there potential for Drug Manufacturers - Specialty & Generic market expansion? Will Emerging introduce new products? Factors like these will boost the valuation of Emerging World. Projected growth potential of Emerging fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Emerging World listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0)
The market value of Emerging World Pharma is measured differently than its book value, which is the value of Emerging that is recorded on the company's balance sheet. Investors also form their own opinion of Emerging World's value that differs from its market value or its book value, called intrinsic value, which is Emerging World's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Emerging World's market value can be influenced by many factors that don't directly affect Emerging World's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Emerging World's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Emerging World should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Emerging World's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.